Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

348
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
348
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

790
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
790
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Inhaled Medications01:23

Inhaled Medications

316
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
316
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

544
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
544
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

778
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
778

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical reinforcement of graphene via wrinkling.

NPJ 2D materials and applications·2026
Same author

Addressing food addiction: A call to examine its prevalence and impact on Indian medical students.

Journal of family medicine and primary care·2025
Same author

Plant extracts with antioxidant and hepatoprotective benefits for liver health: A bibliometric analysis of drug delivery systems.

World journal of gastroenterology·2025
Same author

Primary malignant giant cell tumor (PMGCT): Diagnosis and management challenges in low resource settings.

Narra J·2025
Same author

A rare presentation of pleural pseudocyst in chronic calcific pancreatitis: A case report.

Radiology case reports·2025
Same author

Safeguarding the Heart in Cancer Therapy: Balancing Cardioprotection with Treatment Efficacy.

Journal of pharmacy & bioallied sciences·2025

Related Experiment Video

Updated: Jul 23, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.8K

The Need for Action: Addressing Inhalant Abuse and Whitener Addiction Among Adolescents.

Rashi Chandrakar1, Samriddhi Srivastav1, Vaishnavi Babhulkar1

  • 1Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

Cureus
|July 17, 2023
PubMed
Summary

Inhalant abuse and whitener addiction pose serious risks to adolescent health and well-being. Addressing these issues requires comprehensive strategies including education, early intervention, and community collaboration.

Keywords:
adolescentsawarenessinhalant abusepreventiontreatmentwhitener addiction

More Related Videos

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

950
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

195

Related Experiment Videos

Last Updated: Jul 23, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.8K
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

950
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

195

Area of Science:

  • Public Health
  • Adolescent Medicine
  • Substance Abuse Research

Background:

  • Inhalant abuse and whitener addiction are significant public health concerns affecting adolescents.
  • These substance use disorders have profound negative impacts on physical health, mental well-being, and social functioning.
  • Addressing adolescent inhalant abuse presents unique challenges due to accessibility and societal factors.

Purpose of the Study:

  • To review the causes and health consequences of inhalant abuse and whitener addiction in adolescents.
  • To identify and discuss the challenges associated with preventing and treating adolescent inhalant abuse.
  • To outline effective strategies for addressing inhalant abuse and whitener addiction among youth.

Main Methods:

  • This study is a comprehensive literature review.
  • It synthesizes existing research on adolescent inhalant abuse and whitener addiction.
  • The review examines causes, consequences, and intervention strategies.

Main Results:

  • Adolescent inhalant abuse and whitener addiction are linked to severe physical and mental health issues.
  • Effective strategies include educational campaigns, early intervention, and multi-sectoral collaboration.
  • Support systems for affected families are crucial for successful outcomes.

Conclusions:

  • A coordinated approach involving policymakers, healthcare providers, educators, and communities is essential.
  • Prioritizing adolescent substance abuse prevention and treatment is vital for public health.
  • Intervention and support can mitigate the detrimental effects of inhalant abuse and addiction on young people.